Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Léa, Flippe"'
Autor:
Antoine Freuchet, Apolline Salama, Séverine Bézie, Laurent Tesson, Séverine Rémy, Romain Humeau, Hadrien Règue, Céline Sérazin, Léa Flippe, Pärt Peterson, Nadège Vimond, Claire Usal, Séverine Ménoret, Jean‐Marie Heslan, Franck Duteille, Frédéric Blanchard, Magali Giral, Marco Colonna, Ignacio Anegon, Carole Guillonneau
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 8, Pp n/a-n/a (2022)
Background Immune homeostasis requires fully functional Tregs with a stable phenotype to control autoimmunity. Although IL‐34 is a cytokine first described as mainly involved in monocyte cell survival and differentiation, we recently described its
Externí odkaz:
https://doaj.org/article/66e3ea0bfcc54419864f02858ee50ceb
Autor:
Marine Besnard, Céline Sérazin, Jason Ossart, Anne Moreau, Nadège Vimond, Léa Flippe, Hanna Sein, Grace A. Smith, Stefania Pittaluga, Elise M.N. Ferré, Claire Usal, Ignacio Anegon, Annamari Ranki, Michail S. Lionakis, Pärt Peterson, Carole Guillonneau
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 7 (2022)
Targeted monoclonal antibody (mAb) therapies show great promise for the treatment of transplant rejection and autoimmune diseases by inducing more specific immunomodulatory effects than broadly immunosuppressive drugs routinely used. We recently desc
Externí odkaz:
https://doaj.org/article/3354f3a8b337479b98648db65c0555cf
Autor:
Léa Flippe, Anne Gaignerie, Céline Sérazin, Olivier Baron, Xavier Saulquin, Ignacio Anegon, Laurent David, Carole Guillonneau
Publikováno v:
Cells, Vol 11, Iss 24, p 4046 (2022)
Immunotherapy using primary T cells has revolutionized medical care in some pathologies in recent years, but limitations associated to challenging cell genome edition, insufficient cell number production, the use of only autologous cells, and the lac
Externí odkaz:
https://doaj.org/article/6034d03a1dab409489de347bc0c6ec16
Autor:
Léa Flippe, Anne Gaignerie, Céline Sérazin, Olivier Baron, Xavier Saulquin, Maria Themeli, Carole Guillonneau, Laurent David
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Cell therapy using T cells has revolutionized medical care in recent years but limitations are associated with the difficulty of genome editing of the cells, the production of a sufficient number of cells and standardization of the product. Human plu
Externí odkaz:
https://doaj.org/article/8558bebfde314cf28dbda969ee445d0d
Autor:
Florian Dubois, Anne Gaignerie, Léa Flippe, Jean-Marie Heslan, Laurent Tesson, Mélanie Chesneau, Fabienne Haspot, Sophie Conchon, Laurent David, Sophie Brouard
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243769 (2020)
The success of inducing human pluripotent stem cells (hIPSC) offers new opportunities for cell-based therapy. Since B cells exert roles as effector and as regulator of immune responses in different clinical settings, we were interested in generating
Externí odkaz:
https://doaj.org/article/1807caffb4164881808bdbbac8c004ff
Autor:
Stéphanie Kilens, Dimitri Meistermann, Diego Moreno, Caroline Chariau, Anne Gaignerie, Arnaud Reignier, Yohann Lelièvre, Miguel Casanova, Céline Vallot, Steven Nedellec, Léa Flippe, Julie Firmin, Juan Song, Eric Charpentier, Jenna Lammers, Audrey Donnart, Nadège Marec, Wallid Deb, Audrey Bihouée, Cédric Le Caignec, Claire Pecqueur, Richard Redon, Paul Barrière, Jérémie Bourdon, Vincent Pasque, Magali Soumillon, Tarjei S. Mikkelsen, Claire Rougeulle, Thomas Fréour, Laurent David, The Milieu Intérieur Consortium
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Derivation of human induced pluripotent stem cells (hiPSCs) produces primed hiPSCs that can in turn be converted to naive hiPSCs. Here, the authors directly reprogram somatic cells to form both naive and primed isogenic hiPSCs and confirm the similar
Externí odkaz:
https://doaj.org/article/99050a32ab984d7caf964c0d03730743
Autor:
Léa, Flippe, Anne, Gaignerie, Céline, Sérazin, Olivier, Baron, Xavier, Saulquin, Ignacio, Anegon, Laurent, David, Carole, Guillonneau
Publikováno v:
Cells. 11(24)
Immunotherapy using primary T cells has revolutionized medical care in some pathologies in recent years, but limitations associated to challenging cell genome edition, insufficient cell number production, the use of only autologous cells, and the lac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6a1ceba9354328c610ac73c67f452c6
https://pubmed.ncbi.nlm.nih.gov/36552810
https://pubmed.ncbi.nlm.nih.gov/36552810
Autor:
Antoine Freuchet, Apolline Salama, Séverine Bézie, Laurent Tesson, Séverine Rémy, Romain Humeau, Hadrien Règue, Céline Sérazin, Léa Flippe, Pärt Peterson, Nadège Vimond, Claire Usal, Séverine Ménoret, Jean‐Marie Heslan, Franck Duteille, Frédéric Blanchard, Magali Giral, Marco Colonna, Ignacio Anegon, Carole Guillonneau
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, 2022, 12 (8), ⟨10.1002/ctm2.988⟩
Clinical and Translational Medicine, 2022, 12 (8), ⟨10.1002/ctm2.988⟩
International audience; Background: Immune homeostasis requires fully functional Tregs with a stable phenotype to control autoimmunity. Although IL-34 is a cytokine first described as mainly involved in monocyte cell survival and differentiation, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51cb5e5e543051ad53a7e9c9f8c8b8d
https://hal.science/hal-03852995
https://hal.science/hal-03852995
Autor:
Antoine Freuchet, Apolline Salama, Séverine Bézie, Laurent Tesson, Séverine Rémy, Romain Humeau, Hadrien Règue, Léa Flippe, Pärt Peterson, Nadège Vimond, Claire Usal, Séverine Ménoret, Jean-Marie Heslan, Franck Duteille, Frédéric Blanchard, Magali Giral, Marco Colonna, Ignacio Anegon, Carole Guillonneau
Immune homeostasis requires fully functional Tregs with a stable phenotype to control autoimmunity. Although IL-34 is a cytokine first described as mainly involved in monocyte cell survival and differentiation, we recently described its expression by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f92ef2bff35f868f39effd696a8276f
https://doi.org/10.1101/2022.02.04.479184
https://doi.org/10.1101/2022.02.04.479184
Autor:
Anne Gaignerie, Xavier Saulquin, Céline Sérazin, Laurent David, Carole Guillonneau, Olivier Baron, Ignacio Anegon, Léa Flippe
Publikováno v:
Cells; Volume 11; Issue 24; Pages: 4046
Immunotherapy using primary T cells has revolutionized medical care in some pathologies in recent years, but limitations associated to challenging cell genome edition, insufficient cell number production, the use of only autologous cells, and the lac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c6593928a645e5c8745447d91ca7f3
https://hal.archives-ouvertes.fr/hal-03450516
https://hal.archives-ouvertes.fr/hal-03450516